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Lung cancer is the most prevalent cause of cancer death in most
countries. In several areas the annual incidence rates among males
exceed 100 per 100 000, some of the highest reported for any
malignancy (Blot et al, 1996). Adenocarcinoma, which arises from
glandular epithelia, is a major form of this pathology. Metastatic
spread of primary tumour cells is the main cause of death in onco-
logical patients. Aberrant cell surface glycosylation plays an
important role on tumour cell adhesion to endothelium, a neces-
sary event leading to extravasation into target organs (Hakomori,
1989).
Carcinoma cells are often enriched with sialylated fucosylated
lactosaminoglycans such as sialyl-Lewisx (sialyl-Lex) and sialyl-
Lewisa (sialyl-Lea), which are recognized by the endothelial cell
adhesion molecule E-selectin (Takada et al, 1993; Sawada et al,
1994; Yamada et al, 1997). It has been proposed that E-selectin
promotes attachment of tumour cells to endothelium by molecular
interactions similar to those used in leukocyte recruitment to
inflammation sites (Bevilacqua and Nelson, 1993; Varki, 1994;
Lowe, 1997). The final step in the synthesis of these side-chain
oligosaccharides is dependent on the activity of one or more
specific  a-(1,3)-fucosyltransferases (a-(1,3)-Fuc-Ts), and to date,
five a-(1,3)-Fuc-T genes have been cloned: Fuc-TIII (Kukowska-
Latallo et al, 1990), Fuc-TIV (Goelz et al, 1990; Lowe et al, 1991),
Fuc-TV (Weston et al, 1992a), Fuc-TVI (Weston et al, 1992b) and
Fuc-TVII (Natsuka et al, 1994; Sasaki et al, 1994). These enzymes
catalyse the transfer of fucose to type 2 chain-based structures
(Galb1–4GlcNAc–R) to generate Lex-related molecules and
Fuc-TIII (the Lewis type enzyme) can also efficiently use type 1
carbohydrates (Galb1–3GlcNAc–R) to yield Lea and sialyl-Lea
determinants. Transfection studies have shown that the five known
a-(1,3)-Fuc-T enzymes are able to synthesize the sialyl-Lex deter-
minant, although the role of Fuc-TIV, the myeloid type enzyme, in
this synthesis has only been reported for few cell types such as a
CHO-derived cell line (Goelz et al, 1994). This enzyme has,
however, high affinity for non-sialylated type 2 acceptor and
thus participates on the synthesis of Lewisx antigen. Fuc-TV and
Fuc-TVI (the plasma type enzyme) have the ability to synthesize
Lex and sialyl-Lex (Weston et al, 1992a, 1992b). Fuc-TVII, a
leukocyte-expressed enzyme, is unique in that this enzyme can
synthesize only sialy-Lex (Natsuka et al, 1994; Sasaki et al, 1994).
Several reports have already confirmed the key role of this enzyme
in the control of leukocyte trafficking in health and disease
(Hiraiwa et al, 1996; Maly ´ et al, 1996). Expression of Fuc-TIV and
Fuc-TVII genes had initially been related to poor prognosis in lung
cancers (Ogawa et al, 1996) but, more recently, Fuc-TVII has been
defined as a more important indicator of a poor prognosis by its
participation in sialyl-Lex synthesis (Ogawa et al, 1997).
We have previously demonstrated that the metastatic human
lung adenocarcinoma cell line HAL-8Luc overexpressed a series
of sialylated fucosylated lactosaminoglycans compared to the non-
metastatic HAL-24Luc cells (Martín-Satué et al, 1998). Both cell
lines were derived from the same common parental cell line
KUM-LK-2 using repeated cloning with limiting dilution tech-
nique and intravenous (i.v.) injection in nu/nu mice (Inufusa et al,
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the lungs are the only organs colonized when HAL-8Luc cells
were inoculated either i.v. or intramuscularly (i.m.) in athymic
mice while HAL-24Luc cells did not metastasize. Overexpression
of these oligosaccharides correlated with an increased expression
of the five a-(1,3)-Fuc-T genes and enhanced adhesion to acti-
vated endothelial cells. Results from those in vitro adhesion assays
pointed to the relevance of the sialyl-Lex oligosaccharide in the
binding reaction and indicated a high affinity of this epitope for
E-selectin expressed on endothelial cells. These observations
reinforced previous findings in which sialyl-Lex had been identi-
fied as predicting factor of recurrence in lung adenocarcinoma
patients (Ogawa et al, 1994). The aim of the present work was to
analyse if a(1,3)-Fuc-TIV and a(1,3)-Fuc-TVII overexpression
modifies the adhesive properties and lung colonization potential of
non-metastatic human lung adenocarcinoma HAL-24Luc cells.
MATERIALS AND METHODS
Cell lines
Human lung adenocarcinoma cell lines HAL-8Luc (metastatic)
and HAL-24Luc (non-metastatic) (Martín-Satué et al, 1998) were
maintained in RPMI-1640 (Bio-Whitaker, Verviers, Belgium)
supplemented with 10% (v/v) heat-inactivated fetal bovine serum
(FBS) (Bio-Whitaker), 2 mML -glutamine (Bio-Whitaker), peni-
cillin (100 units ml–1), streptomycin (100 mg ml–1) and 300 mg ml–1
geneticin (G418; Life Technologies, Inc., Grand Island, NY, USA)
in a humidified atmosphere of 5% carbon dioxide at 37°C.
Human umbilical vein endothelial cells (HUVECs) were
isolated by collagenase digestion from multiple segments of
normal-term umbilical cords and cultured as previously described
(López et al, 1993). Adhesion assays were performed using
endothelial cells within three passages.
Plasmids and transfection
Plasmids containing full-length cDNAs for Fuc-TIV (pcDNAI-
a(1,3)FTMlu) and Fuc-TVII (pCDM8-FucTVII) were kindly
donated by Dr John B Lowe from the Howard Hughes Medical
Institute (The University of Michigan Medical Centre, Ann Arbor,
MI, USA). Plasmid pCEP4 encoding hygromycin resistance as
well as the pcDNAI and pCDM8 plasmids were obtained from
Invitrogen (San Diego, CA, USA).
HAL-24Luc cells, which were already neomycin resistants,
were co-transfected by lipofection with each Fuc-T cDNA-
containing plasmid together with the pCEP4 plasmid, using the
method supplied by the manufacturer (Life Technologies, Inc.,
Grand Island, NY, USA). HAL-24Luc cells mock transfected with
pCEP4 and the vector devoid of Fuc-T cDNA were used as control
clones. Transfected cells were selected by supplementing culture
medium with 100 mg ml–1 hygromycin (Boehringer Mannheim,
Mannheim, Germany). After limiting dilution, culture-resistant
clones were analysed for surface antigens expression.
Flow cytometry
Up to 25 HAL-24Luc clones from each transfection were analysed
for cell surface antigen expression by flow cytometric analysis
(Epics XL-MCL, Hialeah, FL, USA) as previously described
(Martín-Satué et al, 1998) using the following primary mono-
clonal antibodies (mAbs): FH6, an IgM anti-sialyl-Lex dimeric,
kindly provided by Otsuka Pharmaceutical (Osaka, Japan);
CSLEX-1, an IgM anti-sialyl-Lex and Leu-M1, an IgM anti-Lex
both purchased from Becton Dickinson (San Jose, CA, USA); LE-
1, an IgM anti-Lea (Ortho Diagnostic, Neckargemünd, Germany);
CA19.9, an IgG1 anti-sialyl-Lea (Novocastra Laboratory Ltd,
Newcastle, UK). These specific antibodies were used at saturating
concentrations determined by titration.
Cells labelled with irrelevant isotypic murine mAbs (mouse
anti-human IgG1 and mouse anti-human IgM from Becton
Dickinson, San Jose, CA, USA) or secondary antibody alone
(fluorescein-conjugated goat anti-mouse IgG; DAKO, A/S,
Copenhagen, Denmark) were used as controls.
Mean channels of fluorescence were recorded for every
analysis, and the ratios of mean channels of fluorescence for each
mAb and control pair were also calculated.
Northern blot
Four micrograms poly-adenosine+ (poly-A+) RNA from trans-
fected and untransfected HAL-24Luc cells were fractionated by
formaldehyde/agarose gel electrophoresis and transferred to nylon
membranes (Hybond-N+; Amersham International, Bucking-
hamshire, UK). The membranes were hybridized with 32P-labelled
cDNA probes in a solution containing 50% (v/v) formamide,
5´ saline–sodium citrate (SSC), 50 mM sodium phosphate buffer
pH 6.5, 250 mg ml–1 sheared salmon sperm DNA, 10 ´ Denhart’s
solution and 10% dextran sulphate overnight at 42°C. Following
hybridization the membranes were washed twice for 10 min at
room temperature in 2 ´ SSC, 0.1% sodium dodecyl sulphate
(SDS) and once in 0.2 ´ SSC, 0.1% SDS for 1 h at 68°C. Finally,
the membranes were autoradiographed by exposure to Hyperfilm
MP (Amersham International, Buckinghamshire, UK). Blots were
stripped and reprobed with human b-actin cDNA as a control for
RNA integrity and loading consistency. Band intensity was
analysed with the Molecular Analyst/PC 1.4 software (BioRad,
Hercules, CA, USA) and calibrated by comparison with the b-
actin bands. Fuc-Ts and b-actin human cDNA probes were
obtained in our laboratory (Martín-Satué et al, 1998).
Endothelial cell adhesion assays
HUVECs were cultured in fibronectin-coated 96-well microtitre
plates. Confluent endothelial cells were induced for E-selectin
expression by incubating with 10 U ml–1 human recombinant inter-
leukin (IL)-1b (Boehringer Mannheim, Mannheim, Germany) for
4 h at 37°C previous to the experiment.
HAL-8Luc, HAL-24Luc and Fuc-T-transfected HAL-24Luc
cells were detached by trypsinization, labelled with 200 mCi of
sodium [51Cr] chromate (Amersham International, Amersham,
UK) and added in RPMI-1640 with 2% FBS to both stimulated
and non-stimulated HUVEC monolayers at a nominal density of
1 ´ 105 per well. After a 30 min incubation period at 4°C non-
adherent cells were removed by aspiration and following two
washes with 2% FBS medium bound cells were lysed with 25 mM
sodium hydroxide, 0.1% SDS and radioactivity was determined
using a g-counter (1261 Multigamma; WALLAC Oy, Türku,
Finland). Adhesion percentages were calculated as the ratio of
bound cell radioactivity to total radioactivity from 1 ´ 105 cells.
For E-selectin blockade, IL-1b-stimulated HUVEC monolayers
were incubated with 10 mg ml–1 anti-human E-selectin mAb, P2H3
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4°C previous to the binding assay.
For inhibition assays, labelled tumour cells were first incubated
with the above described mAbs: Leu-M1, CSLEX-1, FH6, LE-1 or
CA19.9 at a saturating concentration of 50 mg ml–1 for 30 min at
room temperature and then added to HUVEC monolayers. Isotypic
irrelevant murine mAbs (mouse anti-human IgG1 and mouse
anti-human IgM from Becton Dickinson, San Jose, CA, USA)
were used as controls.
Experimental metastasis assay
Metastasis assays were performed on 7-week-old female BALB/c
homozygous nude (nu/nu) mice (CRIFFA S.A., Barcelona, Spain)
maintained in a specific pathogen-free environment.
The above described HAL-24Luc Fuc-T-transfectants (5 ´ 105
cells) suspended in 0.1 ml serum-free RPMI-1640 were injected
in the lateral tail vein to assess for lung colonization potential.
Untransfected HAL-8Luc and HAL-24Luc cells as well as mock-
transfectants were also inoculated as controls in these experiments.
Assays were done in duplicate and five animals were used for each
replica. Animals were sacrified 10 weeks after injections. No
animals died before the time of sacrifice. Following post-mortem
examination, lungs were collected for histopathological analysis.
Samples were fixed in 4% (w/v) paraformaldehyde in 0.1 M PBS
for 2 h at room temperature, dehydrated and paraffin-embedded.
Nominal 6-mm-thick sections were mounted on glass slides and
routinely stained with haematoxylin and eosin. Analysis of these
samples was performed following ‘systematic random sampling’
methodology (Pakkenberg and Gundersen, 1988). Specimens were
observed and photographed with a Reichert-Jung Polyvar2 light
microscope.
RESULTS
Flow cytometry
Fuc-T-transfected HAL-24Luc cell clones were examined by flow
cytometry for surface expression of the following fucosylated
lactosaminoglycans: Lex, sialyl-Lex, sialyl-Lex dimeric, Lea and
sialyl-Lea.
Fuc-TIV transfectants only overexpressed Lex while Fuc-TVII-
transfected cells only showed enhanced expression of sialyl-Lex
oligosaccharide. The highest antigen expressing clone from Fuc-
TIV and Fuc-TVII transfections were named 24FT4 and 24FT7,
respectively, and selected for experiments. The ratios of mean
fluorescence intensity were 172 for Lex in 24FT4 cells and 48
for sialyl-Lex in 24FT7 cells. No significant increases in Lea,
sialyl-Lea or sialyl-Lex dimeric expression were detected in any
of the clones analysed. Mock transfectants displayed the same
antigenic pattern as untransfected cells indicating that the transfec-
tion process did not modify the constitutive expression of these
oligosaccharides. Cytofluorometric results are illustrated in
Figure 1.
Northern blot analysis
All the Fuc-T transfectants expressed higher mRNA levels for the
analysed Fuc-Ts than the parental HAL-24Luc cells or the mock
transfectants (Figure 2). Mock transfectants expressed amounts of
Fuc-TIV mRNA equivalent to those of HAL-24Luc cells, showing
a(1,3)-fucosyltransferase overexpression in lung tumour cells. 1171
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Figure 1 Flow cytometry analysis of HAL-24Luc cells, mock-transfectants
and 24FT4 and 24FT7 clones. Cells were labelled with mAb against Lex
(Leu-M1 mAb), sialyl-Lex (CSLEX-1 mAb), sialyl-Lex dimeric (FH6 mAb), Lea
(LE-1 mAb) and sialyl-Lea (CA19.9 mAb). Bars represent the ratio of mean
fluorescence intensities between each mAb and its control. Data correspond
to one representative of five similar experiments. Notice difference in the
ordinate scalesthat co-transfections did not affect the constitutive Fuc-TIV
expression on these cells. Mock transfectants as well as
HAL-24Luc cells showed undetectable levels of Fuc-TVII
mRNA.
Endothelial cell adhesion assays
We have studied the relative ability of Fuc-T-transfected HAL-
24Luc cell lines, 24FT4 and 24FT7, to adhere to IL-1b-stimulated
HUVEC monolayers. Mock transfected HAL-24Luc cells as well
as metastatic HAL-8Luc cells were also subjected to adhesion
assays and used as controls. Since we have previously shown that
HAL-8Luc cells significantly adhere to E-selectin expressing
HUVEC monolayers (Martín-Satué et al, 1998) we have taken the
amount of HAL-8Luc binding in these adhesion assays as 100%.
Normalized values for the mean and standard deviation (s.d.) of
these binding results are illustrated in Figure 3.
The sialyl-Lex-overexpressing cells 24FT7 showed extensive
adhesion to IL-1b-stimulated HUVEC monolayers, but did not
detectably bind to non-activated endothelial cells. On the contrary,
24FT4 cells were unable to bind to HUVEC cells regardless of
their activation state (Figure 3A). None of the mock-transfectant
clones analysed was able to adhere to endothelial cells, indicating
that transfection process by itself did not alter the adhesive proper-
ties of HAL-24Luc cells.
Blocking of sialyl-Lex oligosaccharides with the CSLEX-1
mAb resulted in 90% inhibition of binding in Fuc-TVII-trans-
fected cells (Figure 3B), demonstrating the key role of this deter-
minant in the adhesion. Moreover, pretreatment of stimulated
HUVEC monolayers with anti-E-selectin mAb completely
abolished the binding of tumour cells. Irrelevant mAbs used as
controls as well as other anti-fucosylated antigen mAbs tested
had no effect on adhesion.
Experimental metastasis assays
To analyse if Fuc-T overexpression in HAL-24Luc cells modifies
their lung colonization potential, we have i.v. inoculated athymic
mice with 3 Lex-overexpressing Fuc-TIV-transfected HAL-24Luc
clones, including the 24FT4 and 4 sialyl-Lex-overexpressing
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Figure 2 Northern blot analysis of mRNA from HAL-24Luc (24), mock-
transfected (M) and Fuc-T-transfected (FT4, FT7) cells. Blots were hybridized
with the 32P-labelled Fuc-TIV and Fuc-TVII cDNA probes as described in
‘Materials and Methods’. After a first autoradiographic exposure, the probes
were stripped out and the blots were rehybridized with the b-actin probe
(b-act). Band sizes are indicated in kilobases at the left of each set
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Figure 3 Adhesion of tumour cells to HUVEC monolayers. Data show
normalized values corresponding to the fraction of bound cells and represent
the means of four different experiments, each performed in six replicates.
(A) Adhesion of: HAL-8Luc, HAL-24Luc, mock-transfected HAL-24Luc,
24FT4 and 24FT7 cells to non-stimulated (solid bars) or IL-1 b-stimulated
(striped bars) HUVECs. (B) Adhesion of 24FT7 cells to IL-1-stimulated
HUVECs after no treatment, pretreatment of tumour cells with an irrelevant
mAb (anti-human IgM), anti-sialyl-Lex mAb or pretreatment of HUVECs with
anti-E-selectin mAb
Table 1 Production of lung metastasis by tumour cells i.v. injected in
athymic mice. Entries in bold indicate the clones whose analysis is described
Cell line Number of mice with lung Total number of lung
metastasis/total colonies/mice
HAL-8Luc 9/10 8–25
HAL-24Luc 0/10 0
Mock-transfected 0/10 0
HAL-24Luc
24FT4 0/10 0
24FT4b 0/5 0
24FT4c 0/5 0
24FT7 8/10 4–30
24FT7b 4/5 5–20
24FT7c 4/5 10–25
24FT7d 3/5 7–20Fuc-TVII-transfected HAL-24Luc clones, including the 24FT7.
Untransfected HAL-8Luc, HAL-24Luc cells and HAL-24Luc
mock transfectants were also inoculated and used as controls in
these experiments.
Seventy-six per cent (19 of 25) mice i.v. inoculated with
Fuc-TVII-overexpressing HAL-24Luc cells developed lung
metastases. Similarly, 90% (nine of ten) mice i.v. inoculated with
HAL-8Luc cells and used as positive controls for the inoculation
procedure, developed pulmonary colonies. No metastases were
detected in mice i.v. inoculated with either untransfected, mock-
transfected or Fuc-TIV-overexpressing HAL-24Luc cells. These
results are summarized in Table 1.
Metastases derived from mice i.v. inoculated with Fuc-TVII-
overexpressing HAL-24Luc cells were associated with the
basal lamina of the terminal bronchiole epithelium as was also
previously described for the HAL-8Luc-inoculated mice
(Martín-Satué et al, 1998). A typical lung metastasis from
24FT7-inoculated mouse is shown in Figure 4.
DISCUSSION
Side-chain oligosaccharides such as sialyl-Lex and sialyl-Lea in
both glycolipids and glycoproteins on the surface of tumour cells
had already been identified as tumour-associated antigens
(Hakomori, 1989). More recently, these epitopes have also been
characterized as E- and P-selectin counter-receptors expressed in
several leukocyte subsets and participate in the recruitment of
leukocytes during inflammation (Varki, 1994). Similar mecha-
nisms have been proposed to participate in the metastatic spread of
primary tumour cells. It has been suggested that P-selectin may
mediate the formation of large aggregates of tumour cells and
platelets that could be retained in the thin capillaries of the lung
promoting growth and organ colonization (Kim et al, 1998).
Previous reports have shown that sialyl-Lex expression might be a
useful indicator of blood vessel invasion and recurrence in lung
adenocarcinoma (Ogawa et al, 1994). We have also demonstrated
that enhanced surface display of sialyl-Lex on human lung adeno-
carcinoma cells correlated with their metastatic ability and partici-
pated in the adhesion of tumour cells to E-selectin-expressing
endothelial cells (Martín-Satué et al, 1998). Expression of a-(1,3)-
Fuc-TVII gene has also been related to poor prognosis in lung
cancer because of its participation in sialyl-Lex synthesis (Ogawa
et al, 1997). To determine the role of Fuc-TIV and Fuc-TVII in
the metastatic behaviour of lung adenocarcinoma cells we have
overexpressed these enzymes in the non-metastatic HAL-24Luc
cells.
In the present work, we have stably transfected the non-
metastatic human lung adenocarcinoma HAL-24Luc cell line with
cDNAs encoding the a-(1,3)-Fuc-TIV and VII enzymes and
analysed the resulting changes in antigenic expression, adhesive
ability and metastatic potential of the transfected cell lines. Our
cytofluorometric results indicated that 24FT4 and 24FT7 cells
exclusively overexpressed Lex and sialyl-Lex determinants respec-
tively. FH6 mAb did not detect any increase in sialyl-Lex dimeric
antigen expression. Neither Lea nor sialyl-Lea had been expressed
in any of the clones analysed, and both showed the same
background expression level as the parental HAL-24Luc cells
confirming that neither of these enzymes recognize type 1 chain
oligosaccharides. The pattern of Lewis-related antigens displayed
by the transfectants studied in this work is in accordance with
that from previously reported transfection experiments in which
Fuc-Ts were overexpressed in other cell lines such as CHO or
leukocyte-derived cells (Natsuka et al, 1994; Sasaki et al, 1994).
Synthesis of sialyl-Lex involves sialylation of a type 2 lactosamine
core (Galb1–4GlcNAc–R) followed by the addition of one fucosyl
residue. Untransfected HAL-24Luc cells did not produce sialyl-
Lex but Fuc-TVII transfection of these cells resulted in sialyl-Lex
overexpression, indicating that the sialylated intermediates are not
the limiting molecules and pointing to the relevance of Fuc-TVII
in this reaction.
Endothelial cell adhesion experiments performed with the
selected Fuc-T transfectants showed that only sialyl-Lex-over-
expressing HAL-24Luc cells (24FT7 clone) had the ability to bind
to IL-1-stimulated HUVECs in contrast with the null adhesion
capacity displayed by 24FT4, mock-transfected or untransfected
cells. Binding inhibition achieved either by blocking sialyl-Lex on
the tumour cells or by E-selection blockade on HUVECs empha-
sized the key role of these molecules in the binding reaction.
By inoculation of transfected cells in athymic mice we demon-
strated that Fuc-TVII overexpression is sufficient for acquisition
of lung colonization phenotype by HAL-24Luc cells. The absence
of metastatic foci in 24FT4-inoculated mice is likely related to the
null in vitro E-selectin adhesion capacity shown by these cells. Our
experiments strongly suggest the participation of the endothelial
E-selectin in the initial stages of lung colonization by the HAL
adenocarcinoma cells. Although in a different cell system, the
existence of a mechanism similar to that described by Kim et al
(1998) contributing to colonization can not be excluded.
Furthermore, it may help explain organ selectivity.
The fact that the sole Fuc-TVII transfection rendered the
HAL-24Luc cells metastatic emphasizes the convenience in using
models consisting of genetically closely related cell lines such as
the HAL-8Luc/HAL-24Luc for this work. Our results not only
reinforce previous findings in which Fuc-TVII expression has
been reported as an indicator of poor prognosis in lung carcinoma
(Ogawa et al, 1996, 1997), but also directly demonstrate for the
first time the role of this enzyme on the acquisition of lung
colonization behaviour by human lung adenocarcinoma cells.
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